Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares traded down 27% on Wednesday . The company traded as low as GBX 7.38 ($0.10) and last traded at GBX 9.85 ($0.13). 62,044 shares traded hands during mid-day trading, a decline of 74% from the average session volume of 236,416 shares. The stock had previously closed at GBX 13.50 ($0.18).
Celadon Pharmaceuticals Price Performance
The stock has a market capitalization of £7.24 million, a price-to-earnings ratio of -1.48 and a beta of -0.26. The company has a quick ratio of 6.97, a current ratio of 1.92 and a debt-to-equity ratio of 196.67. The business has a 50-day simple moving average of GBX 18.49 and a two-hundred day simple moving average of GBX 23.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
See Also
- Five stocks we like better than Celadon Pharmaceuticals
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Calculate Inflation Rate
- 3 Must-Own Stocks to Build Wealth This Decade
- Election Stocks: How Elections Affect the Stock Market
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
